Inhibitory effects of bromocriptine on vascular smooth muscle cell proliferation

scientific article published on 01 August 1997

Inhibitory effects of bromocriptine on vascular smooth muscle cell proliferation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0021-9150(97)00113-5
P698PubMed publication ID9258405

P2093author name stringY Zhang
A H Cincotta
P2860cites workThe protein kinase C familyQ28190050
The role of protein kinase C in cell surface signal transduction and tumour promotionQ29618532
d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant propertiesQ33654586
D2 dopaminergic receptors: normal and abnormal transduction mechanismsQ35223636
Localisation of dopamine D2-like receptors in pulmonary artery of the human and rabbit but not of the rat.Q36711491
Insulin and atheroma. 20-yr perspectiveQ37934803
Protein kinase C--a family affairQ38688730
Studies on the Inhibition of Adrenaline-Induced Aggregation of Blood PlateletsQ39294869
The safety of bromocriptine in hyperprolactinaemic female infertility: a literature reviewQ39738904
The pathogenesis of atherosclerosis (second of two parts)Q40547842
Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologiesQ40786541
Characterization of two putative smooth muscle cell lines from rat thoracic aortaQ42803049
A common sequence of calcium and pH signals in the mitogenic stimulation of eukaryotic cellsQ42816404
A synthetic peptide substrate for selective assay of protein kinase CQ44530639
Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic miceQ50198681
Intramural delivery of agent via a novel drug-delivery sleeve. Histological and functional evaluation.Q52507985
Prolactin induces proliferation of vascular smooth muscle cells through a protein kinase C-dependent mechanismQ67926701
Effects of protein kinase inhibitors on growth factor-stimulated DNA synthesis in cultured rat vascular smooth muscle cellsQ68104194
Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cellsQ68753569
Reductions of body fat stores and total plasma cholesterol and triglyceride concentrations in several species by bromocriptine treatmentQ69409960
One minute of bromocriptine irreversibly inhibits prolactin release for hoursQ71352730
Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus)Q71521579
The antimitotic effect of bromocriptine on human fibroblastsQ72785520
P433issue1
P304page(s)37-44
P577publication date1997-08-01
P1433published inAtherosclerosisQ4813570
P1476titleInhibitory effects of bromocriptine on vascular smooth muscle cell proliferation
P478volume133

Reverse relations

cites work (P2860)
Q35153082Bromocriptine in type 2 diabetes mellitus
Q45193317Bromocriptine modulates the expression of PTHrP receptor, Indian hedgehog, and Runx2 proteins in the growth plate of lactating rats
Q34718312Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes
Q38111703Dopamine and renal function and blood pressure regulation
Q48153941Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure
Q37043602Inhibitory effect of the D(3) dopamine receptor on insulin receptor expression and function in vascular smooth muscle cells
Q33862443Platelets and restenosis
Q34169999Stimulus-specific activation and actin dependency of distinct, spatially separated ERK1/2 fractions in A7r5 smooth muscle cells